These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 5789103
1. Arvin treatment in sickle-cell crisis. Reid HA, Galles HM. Trans R Soc Trop Med Hyg; 1969; 63(1):22-3. PubMed ID: 5789103 [No Abstract] [Full Text] [Related]
2. Therapeutic defibrination by ancrod (Arvin). Reid HA. Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):209-15. PubMed ID: 4106010 [No Abstract] [Full Text] [Related]
7. [Therapy of sickle cell crisis]. Janka-Schaub G. Dtsch Med Wochenschr; 1990 Oct 19; 115(42):1611. PubMed ID: 2226160 [No Abstract] [Full Text] [Related]
8. Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis. Lonsdorfer J, Castaigne JP, Lenormand E, Otayeck A, Bogui P, Dosso Y, Cabannes R. Agents Actions Suppl; 1984 Oct 19; 15():213-8. PubMed ID: 6592944 [No Abstract] [Full Text] [Related]
11. Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises. Cabannes R, Lonsdorfer J, Castaigne JP, Ondo A, Plassard A, Zohoun I. Agents Actions Suppl; 1984 Oct 19; 15():199-212. PubMed ID: 6385647 [No Abstract] [Full Text] [Related]
12. Experience with promazine in sickle cell disease. Lewis RA. West Afr Med J Niger Pract; 1968 Oct 19; 17(5):142-8. PubMed ID: 5700122 [No Abstract] [Full Text] [Related]
13. [Clinico-experimental contribution to the antiviral action of the anticoagulant fraction of Bothrops jararaca in the treatment of chickenpox]. Laterza G, De Serio A. Minerva Pediatr; 1967 Jan 07; 19(1):16-8. PubMed ID: 5628119 [No Abstract] [Full Text] [Related]
14. Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries. Svarch E, Machín S, Nieves RM, Mancia de Reyes AG, Navarrete M, Rodríguez H. Pediatr Blood Cancer; 2006 Jul 07; 47(1):111-2. PubMed ID: 16550531 [No Abstract] [Full Text] [Related]
15. Differentiating vaso-occlusive crisis and infection in sickle cell anemia. Shah Y, Kumar A. J Fam Pract; 1981 Oct 07; 13(5):752, 757. PubMed ID: 7276882 [No Abstract] [Full Text] [Related]
16. [Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease]. Monnet D, Diallo I, Sangare A, Yapo AE. Bull Soc Pathol Exot; 1993 Oct 07; 86(4):282-5. PubMed ID: 8292921 [Abstract] [Full Text] [Related]
17. Ascorbic acid in sickle cell disease: results of a pilot therapeutic trial. Akinkugbe FM, Ette SI. East Afr Med J; 1983 Oct 07; 60(10):683-7. PubMed ID: 6671426 [No Abstract] [Full Text] [Related]
18. [Pediatric management of sickle cell disease: experience at the Charles de Gaulle University Children's Hospital in Ouagadougou (Burkina Faso)]. Yé D, Kouéta F, Dao L, Kaboret S, Sawadogo A. Sante; 2008 Oct 07; 18(2):71-5. PubMed ID: 19188129 [Abstract] [Full Text] [Related]
19. Hydroxyurea in very young children with sickle cell anemia is not a cure-all. Powars DR. J Pediatr; 2001 Dec 07; 139(6):763-4. PubMed ID: 11743496 [No Abstract] [Full Text] [Related]
20. The effect of Arvin on blood-coagulation and patency of venovenous shunts in the dog. Van der Ziel C, Joison J, Siso H, Saravis C, Slapak M. Br J Surg; 1970 Nov 07; 57(11):856. PubMed ID: 5482293 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]